Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
about
Reproducible doxycycline-inducible transgene expression at specific loci generated by Cre-recombinase mediated cassette exchange.Evaluation of schistosome promoter expression for transgenesis and genetic analysisOptical Tools To Study the Isoform-Specific Roles of Small GTPases in Immune Cells.Improved conditional expression systems resulting in physiological level of HNF4alpha expression confirm HNF4alpha induced apoptosis in the pancreatic beta-cell line INS-1.Systematic comparison of constitutive promoters and the doxycycline-inducible promoter.Characterization of a heat resistant beta-glucosidase as a new reporter in cells and mice.Rapid obtention of stable, bioluminescent tumor cell lines using a tCD2-luciferase chimeric construct.Nebulisation of receptor-targeted nanocomplexes for gene delivery to the airway epithelium.Establishment of clonal MIN-O transplant lines for molecular imaging via lentiviral transduction & in vitro culture.Genetically modified pigs produced with a nonviral episomal vector.A modified screening system for loss-of-function and dominant negative alleles of essential MCMV genes.Lentiviral mediated gene delivery to the anterior chamber of rodent eyesA comparative analysis of constitutive promoters located in adeno-associated viral vectors.Reprogramming cell fate with a genome-scale library of artificial transcription factors.HTLV-2 Tax immortalizes human CD4+ memory T lymphocytes by oncogenic activation and dysregulation of autophagy.Development of an inducible gene expression system for primary murine keratinocytesPolyplex exposure inhibits cell cycle, increases inflammatory response, and can cause protein expression without cell division.Coexpression of vascular endothelial growth factor and interleukin-1 receptor antagonist for improved human islet survival and function.Toll-Like Receptor 9 Activation Rescues Impaired Antibody Response in Needle-free Intradermal DNA VaccinationThe EF-1α promoter maintains high-level transgene expression from episomal vectors in transfected CHO-K1 cells.Homogeneity and persistence of transgene expression by omitting antibiotic selection in cell line isolation.Homologous recombination is required for AAV-mediated gene targeting.Lentiviral Based Gene Transduction and Promoter Studies in Human Hematopoietic Stem Cells (hHSCs)Comparison of HCMV IE and EF-1 promoters for the stable expression of beta-subunit of hexosaminidase in CHO cell lines.Construction of an eGFP Expression Plasmid under Control of T7 Promoter and IRES Sequence for Assay of T7 RNA Polymerase Activity in Mammalian Cell Lines.Use of the Ki67 promoter to label cell cycle entry in living cells.Developmental Testicular Expression, Cloning, and Characterization of Rat HDAC6 In Silico.In vivo genome editing in animals using AAV-CRISPR system: applications to translational research of human disease.Introduction of Exogenous HSV-TK Suicide Gene Increases Safety of Keratinocyte-Derived Induced Pluripotent Stem Cells by Providing Genetic "Emergency Exit" Switch.Improving the Transduction of Bone Marrow-Derived Cells with an Integrase-Defective Lentiviral Vector.
P2860
Q24814865-076CBD37-51DC-4692-8925-AD9AF9CFB095Q28539112-CC2E5D39-3BDE-4058-A25F-579567EF2A36Q30738195-28B288C8-5EDD-4BD3-BB1A-8E12B44B508CQ33511037-438F78E0-6965-40BD-B051-ED9C3B263064Q33582194-05E3CD83-4319-4349-84D1-A7A5BCD8F1D8Q33613071-8E17E202-BD3F-4BA2-9B27-CA7871222762Q33854934-50F8343D-69D9-40A8-9872-56FA29A421DAQ34064665-291BC78E-DB53-4FB3-A0B6-35AE0D1A4F21Q34321345-53064EA5-79D7-4D9A-8CC5-D067754ADE74Q34581389-77F74A8E-1843-4472-BBBD-46DEBD4B04A8Q35148119-18833579-B94A-41F7-8B49-E70E6968A40DQ35153670-25B21EF0-88BE-4F0D-B4E4-DE18D466605FQ35234995-A4963A33-ED0B-4287-8FB5-F282E129915DQ36215800-18F48B3B-F77A-4E5F-9E3C-816DFF8C8912Q36298491-4FF9F466-0808-4049-9979-4A38E2171908Q36464934-5639C294-368E-4DA1-9649-A7BE28EC9A4EQ36798836-016D6CB5-EDA9-4FFA-A151-3F28D7CD5764Q36852073-15ED0C10-7BD8-4216-A291-A26EBB4CBFCAQ37277900-B0146D3A-4528-4B36-ADDD-88A286BD2A4EQ38430935-E019A7EE-DA98-42A7-917F-FF7425730262Q39953645-D2A7E1EA-6F5D-4DB8-8439-0E7EDB2A215AQ40258601-9EED8CD0-F6ED-4DF1-8B4F-9DFEAEC08448Q41787097-9232AF03-377D-44FA-BEEE-603CB1B10806Q42155604-B59E54CB-8F5E-4B0B-9EB8-96448025D1D2Q42186223-3B306109-17DC-4985-9224-65050D6156A0Q42540910-D3AFBF09-E278-4AF2-9C14-7D54444820F0Q45767810-DE3C6F7B-B853-43EA-BB17-4F25E395505CQ47553772-85060E08-5922-4D4E-B22B-1A9718413159Q47556660-BC3B911F-9488-45DD-BA68-443E7CF2C920Q47574712-F3782F47-2194-4DA9-9529-2681F2A4A048
P2860
Comparison of the EF-1 alpha and the CMV promoter for engineering stable tumor cell lines using recombinant adeno-associated virus.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Comparison of the EF-1 alpha a ...... binant adeno-associated virus.
@en
Comparison of the EF-1 alpha a ...... binant adeno-associated virus.
@nl
type
label
Comparison of the EF-1 alpha a ...... binant adeno-associated virus.
@en
Comparison of the EF-1 alpha a ...... binant adeno-associated virus.
@nl
prefLabel
Comparison of the EF-1 alpha a ...... binant adeno-associated virus.
@en
Comparison of the EF-1 alpha a ...... binant adeno-associated virus.
@nl
P2093
P1433
P1476
Comparison of the EF-1 alpha a ...... mbinant adeno-associated virus
@en
P2093
Christian Teschendorf
Dietmar W Siemann
Kenneth H Warrington
Nicholas Muzyczka
P304
P407
P577
2002-11-01T00:00:00Z